NDC 85043-030-03
Vabrinty 30 mg/.5mL
Leuprolide acetate · INJECTION, SUSPENSION, EXTENDED RELEASE
Vabrinty is a injection, suspension, extended release containing leuprolide acetate at a strength of 30 mg/.5mL. Manufactured by URONOVA PHARMACEUTICALS, INC..
Key Facts
- Brand Name
- Vabrinty
- Generic Name
- Leuprolide acetate
- NDC Code (Package)
85043-030-03- NDC Code (Product)
85043-030- Manufacturer
- URONOVA PHARMACEUTICALS, INC.
- Strength
- 30 mg/.5mL
- Dosage Form
- INJECTION, SUSPENSION, EXTENDED RELEASE
- Route
- SUBCUTANEOUS
- Marketing Status
- Application #
- NDA021488
- Marketing Start
- 08/04/2025
Recall History
No Recall HistoryView Full Drug Page
Vabrinty — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.